{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:46:19Z","timestamp":1790480779905,"version":"4.1.0"},"reference-count":72,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,12,19]]},"abstract":"<jats:p>This article reports a novel mechanism by which Epstein-Barr virus (EBV) microRNA (miRNA) plays a role to fine-tune the expression of LMP1-driven amplification of inhibitory checkpoint programmed death ligand 1 (PD-L1) and PD-L2 in EBV+ diffuse large B-cell lymphoma. Identification and understanding of the immune checkpoint regulation via miRNA may enable potential novel RNA-based therapies to emerge.<\/jats:p>","DOI":"10.1182\/blood.2019000889","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T11:03:45Z","timestamp":1573038225000},"page":"2261-2270","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":62,"title":["EBV microRNA-BHRF1-2-5p targets the 3\u2032UTR of immune checkpoint ligands PD-L1 and PD-L2"],"prefix":"10.1182","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3468-0919","authenticated-orcid":false,"given":"Alexandre S.","family":"Cristino","sequence":"first","affiliation":[{"name":"Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD, Australia;"},{"name":"Diamantina Institute, University of Queensland, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Nourse","sequence":"additional","affiliation":[{"name":"Queensland Institute of Medical Research, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3162-4425","authenticated-orcid":false,"given":"Rachael A.","family":"West","sequence":"additional","affiliation":[{"name":"Diamantina Institute, University of Queensland, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed Bilal","family":"Sabdia","sequence":"additional","affiliation":[{"name":"Mater Research, University of Queensland, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0782-6951","authenticated-orcid":false,"given":"Soi C.","family":"Law","sequence":"additional","affiliation":[{"name":"Mater Research, University of Queensland, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2695-3849","authenticated-orcid":false,"given":"Jay","family":"Gunawardana","sequence":"additional","affiliation":[{"name":"Mater Research, University of Queensland, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Vari","sequence":"additional","affiliation":[{"name":"Queensland Institute of Medical Research, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Mujaj","sequence":"additional","affiliation":[{"name":"Queensland Institute of Medical Research, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayathri","family":"Thillaiyampalam","sequence":"additional","affiliation":[{"name":"Diamantina Institute, University of Queensland, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7847-3041","authenticated-orcid":false,"given":"Cameron","family":"Snell","sequence":"additional","affiliation":[{"name":"Mater Research, University of Queensland, Brisbane, QLD, Australia;"},{"name":"Mater Pathology, Brisbane, QLD, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Gough","sequence":"additional","affiliation":[{"name":"Mater Research, University of Queensland, Brisbane, QLD, Australia;"},{"name":"Mater Pathology, Brisbane, QLD, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Keane","sequence":"additional","affiliation":[{"name":"Mater Research, University of Queensland, Brisbane, QLD, Australia;"},{"name":"Princess Alexandra Hospital, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1000-5393","authenticated-orcid":false,"given":"Maher K.","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Mater Research, University of Queensland, Brisbane, QLD, Australia;"},{"name":"Princess Alexandra Hospital, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019121906525052800_B1","first-page":"291","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Gascoyne","year":"2017"},{"key":"2019121906525052800_B2","first-page":"304","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Nakamura","year":"2017"},{"issue":"6769","key":"2019121906525052800_B3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"13","key":"2019121906525052800_B4","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas","volume":"350","author":"Thorley-Lawson","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"2019121906525052800_B5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2013-03-489708","article-title":"EBV-positive diffuse large B-cell lymphoma of the elderly","volume":"122","author":"Ok","year":"2013","journal-title":"Blood"},{"issue":"21","key":"2019121906525052800_B6","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2018-10-879015","article-title":"PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype","volume":"133","author":"Godfrey","year":"2019","journal-title":"Blood"},{"issue":"10","key":"2019121906525052800_B7","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/S2352-3026(15)00150-7","article-title":"Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study","volume":"2","author":"Keane","year":"2015","journal-title":"Lancet Haematol"},{"issue":"7338","key":"2019121906525052800_B8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"issue":"7","key":"2019121906525052800_B9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","article-title":"Targetable genetic features of primary testicular and primary central nervous system lymphomas","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"issue":"9","key":"2019121906525052800_B10","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1182\/blood-2015-11-683003","article-title":"Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas","volume":"128","author":"Chong","year":"2016","journal-title":"Blood"},{"issue":"13","key":"2019121906525052800_B11","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","article-title":"Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma","volume":"123","author":"Twa","year":"2014","journal-title":"Blood"},{"issue":"7607","key":"2019121906525052800_B12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3\u2032-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"issue":"7","key":"2019121906525052800_B13","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41375-019-0380-5","article-title":"Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas","volume":"33","author":"Kataoka","year":"2019","journal-title":"Leukemia"},{"issue":"6","key":"2019121906525052800_B14","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","article-title":"Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy","volume":"18","author":"Green","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2019121906525052800_B15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41375-018-0178-x","article-title":"Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas","volume":"33","author":"Anastasiadou","year":"2019","journal-title":"Leukemia"},{"issue":"3","key":"2019121906525052800_B16","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1371\/journal.ppat.0020023","article-title":"Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed","volume":"2","author":"Cai","year":"2006","journal-title":"PLoS Pathog"},{"issue":"5","key":"2019121906525052800_B17","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1128\/JVI.02104-08","article-title":"Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma","volume":"83","author":"Cosmopoulos","year":"2009","journal-title":"J Virol"},{"issue":"11","key":"2019121906525052800_B18","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12858","article-title":"A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors","volume":"14","author":"Fink","year":"2014","journal-title":"Am J Transplant"},{"issue":"5","key":"2019121906525052800_B19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1261\/rna.2326106","article-title":"A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses","volume":"12","author":"Grundhoff","year":"2006","journal-title":"RNA"},{"issue":"1-2","key":"2019121906525052800_B20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jviromet.2012.05.005","article-title":"Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples","volume":"184","author":"Nourse","year":"2012","journal-title":"J Virol Methods"},{"issue":"5671","key":"2019121906525052800_B21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1096781","article-title":"Identification of virus-encoded microRNAs","volume":"304","author":"Pfeffer","year":"2004","journal-title":"Science"},{"issue":"7","key":"2019121906525052800_B22","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1128\/JVI.01689-08","article-title":"Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas","volume":"83","author":"Zhu","year":"2009","journal-title":"J Virol"},{"issue":"12","key":"2019121906525052800_B23","doi-asserted-by":"crossref","first-page":"E2540","DOI":"10.3390\/ijms18122540","article-title":"The roles of microRNAs in regulating the expression of PD-1\/PD-L1 immune checkpoint","volume":"18","author":"Wang","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2019121906525052800_B24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ijc.2910030619","article-title":"Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus","volume":"3","author":"Pope","year":"1968","journal-title":"Int J Cancer"},{"issue":"9","key":"2019121906525052800_B25","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1128\/JVI.02630-07","article-title":"Distinct ex vivo susceptibility of B-cell subsets to epstein-barr virus infection according to differentiation status and tissue origin","volume":"82","author":"Dorner","year":"2008","journal-title":"J Virol"},{"issue":"7","key":"2019121906525052800_B26","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1089\/10430340252898993","article-title":"Use of spontaneous Epstein-Barr virus-lymphoblastoid cell lines genetically modified to express tumor antigen as cancer vaccines: mutated p21 ras oncogene in pancreatic carcinoma as a model","volume":"13","author":"Kubuschok","year":"2002","journal-title":"Hum Gene Ther"},{"issue":"3","key":"2019121906525052800_B27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/ejh.13274","article-title":"The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma","volume":"103","author":"Keane","year":"2019","journal-title":"Eur J Haematol"},{"issue":"16","key":"2019121906525052800_B28","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2017-07-796342","article-title":"Immune evasion via PD-1\/PD-L1 on NK cells and monocyte\/macrophages is more prominent in Hodgkin lymphoma than DLBCL","volume":"131","author":"Vari","year":"2018","journal-title":"Blood"},{"key":"2019121906525052800_B29","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1038\/ncomms6529","article-title":"Neuroligin-associated microRNA-932 targets actin and regulates memory in the honeybee","volume":"5","author":"Cristino","year":"2014","journal-title":"Nat Commun"},{"issue":"1","key":"2019121906525052800_B30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/bioinformatics\/18.1.207","article-title":"Genesis: cluster analysis of microarray data","volume":"18","author":"Sturn","year":"2002","journal-title":"Bioinformatics"},{"issue":"8","key":"2019121906525052800_B31","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1002\/eji.1830270835","article-title":"B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production","volume":"27","author":"Agematsu","year":"1997","journal-title":"Eur J Immunol"},{"issue":"6","key":"2019121906525052800_B32","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/00000478-200006000-00010","article-title":"CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas","volume":"24","author":"Dogan","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2019121906525052800_B33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2008.04.020","article-title":"TIMP1 induces CD44 expression and the activation and nuclear translocation of SHP1 during the late centrocyte\/post-germinal center B cell differentiation","volume":"269","author":"Kim","year":"2008","journal-title":"Cancer Lett"},{"issue":"7","key":"2019121906525052800_B34","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/ni1357","article-title":"Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination","volume":"7","author":"Klein","year":"2006","journal-title":"Nat Immunol"},{"issue":"26","key":"2019121906525052800_B35","doi-asserted-by":"crossref","first-page":"18470","DOI":"10.1074\/jbc.274.26.18470","article-title":"Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells","volume":"274","author":"Muramatsu","year":"1999","journal-title":"J Biol Chem"},{"issue":"4","key":"2019121906525052800_B36","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1182\/blood-2006-08-039024","article-title":"The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas","volume":"109","author":"Natkunam","year":"2007","journal-title":"Blood"},{"issue":"12","key":"2019121906525052800_B37","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nri2204","article-title":"BLIMP1 guides the fate of effector B and T cells","volume":"7","author":"Nutt","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2019121906525052800_B38","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1101\/gad.11.4.476","article-title":"Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus","volume":"11","author":"Nutt","year":"1997","journal-title":"Genes Dev"},{"issue":"4","key":"2019121906525052800_B39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/08830189909088490","article-title":"Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6","volume":"18","author":"Staudt","year":"1999","journal-title":"Int Rev Immunol"},{"issue":"4","key":"2019121906525052800_B40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.smim.2004.08.005","article-title":"Evolution of isotype switching","volume":"16","author":"Stavnezer","year":"2004","journal-title":"Semin Immunol"},{"issue":"10","key":"2019121906525052800_B41","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1182\/blood-2002-08-2673","article-title":"Gene expression profiling reveals a highly specialized genetic program of plasma cells","volume":"101","author":"Underhill","year":"2003","journal-title":"Blood"},{"issue":"16","key":"2019121906525052800_B42","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1182\/blood-2008-10-183632","article-title":"Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting","volume":"113","author":"Longo","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2019121906525052800_B43","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.20080809","article-title":"Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis","volume":"205","author":"Brune","year":"2008","journal-title":"J Exp Med"},{"issue":"5","key":"2019121906525052800_B44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/intimm\/3.5.467","article-title":"Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways","volume":"3","author":"Cong","year":"1991","journal-title":"Int Immunol"},{"issue":"25","key":"2019121906525052800_B45","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2009-07-235960","article-title":"An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization","volume":"114","author":"Jourdan","year":"2009","journal-title":"Blood"},{"issue":"17","key":"2019121906525052800_B46","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"36","key":"2019121906525052800_B47","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"2019121906525052800_B48","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"2019121906525052800_B49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1586\/14787210.4.1.77","article-title":"Epstein-Barr virus-associated lymphomas","volume":"4","author":"Gandhi","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"23","key":"2019121906525052800_B50","doi-asserted-by":"crossref","first-page":"11115","DOI":"10.1128\/JVI.74.23.11115-11120.2000","article-title":"Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines","volume":"74","author":"Yoo","year":"2000","journal-title":"J Virol"},{"issue":"14-15","key":"2019121906525052800_B51","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.micinf.2011.07.007","article-title":"The role of microRNAs in Epstein-Barr virus latency and lytic reactivation","volume":"13","author":"Forte","year":"2011","journal-title":"Microbes Infect"},{"issue":"1","key":"2019121906525052800_B52","first-page":"djv303","article-title":"PDL1 regulation by p53 via miR-34","volume":"108","author":"Cortez","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"2019121906525052800_B53","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1371\/journal.pbio.0020363","article-title":"Human microRNA targets [published correction appears in PLoS Biol. 2005;3(7):e264]","volume":"2","author":"John","year":"2004","journal-title":"PLoS Biol"},{"issue":"3","key":"2019121906525052800_B54","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood-2007-10-117655","article-title":"LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1","volume":"111","author":"Rastelli","year":"2008","journal-title":"Blood"},{"issue":"23","key":"2019121906525052800_B55","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.18632\/oncotarget.2608","article-title":"EBV-driven LMP1 and IFN-\u03b3 up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy","volume":"5","author":"Fang","year":"2014","journal-title":"Oncotarget"},{"issue":"3","key":"2019121906525052800_B56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bbamcr.2015.11.003","article-title":"Tumor microenvironment (TME)-driven immune suppression in B cell malignancy","volume":"1863","author":"Nicholas","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"13","key":"2019121906525052800_B57","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1182\/blood-2010-03-274076","article-title":"Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders","volume":"116","author":"Jones","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2019121906525052800_B58","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1600-6143.2011.03499.x","article-title":"Epstein-Barr Virus-related post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy","volume":"11","author":"Nourse","year":"2011","journal-title":"Am J Transplant"},{"issue":"7","key":"2019121906525052800_B59","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1158\/1078-0432.CCR-16-1576","article-title":"The T-cell receptor repertoire influences the tumor microenvironment and is associated with survival in aggressive B-cell lymphoma","volume":"23","author":"Keane","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2019121906525052800_B60","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","article-title":"EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment","volume":"126","author":"Nicolae","year":"2015","journal-title":"Blood"},{"issue":"13","key":"2019121906525052800_B61","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2019121906525052800_B62","article-title":"Clinicopathological evaluation of PD1\/PD-L1 axis in post-transplant lymphoproliferative disorders: association with EBV, PD-L1 copy number alterations and outcome [published online ahead of print 12 March 2019]","author":"Veloza","journal-title":"Histopathology"},{"issue":"2","key":"2019121906525052800_B63","first-page":"146","article-title":"Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopes","volume":"1","author":"Nguyen-Van","year":"2011","journal-title":"Am J Blood Res"},{"issue":"9","key":"2019121906525052800_B64","doi-asserted-by":"crossref","first-page":"e0136476","DOI":"10.1371\/journal.pone.0136476","article-title":"PD-1 blockade can restore functions of T-cells in Epstein-Barr virus-positive diffuse large B-cell lymphoma in vitro","volume":"10","author":"Quan","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"2019121906525052800_B65","doi-asserted-by":"crossref","first-page":"e1005642","DOI":"10.1371\/journal.ppat.1005642","article-title":"PD-1\/CTLA-4 blockade inhibits Epstein-Barr virus-induced lymphoma growth in a cord blood humanized-mouse model","volume":"12","author":"Ma","year":"2016","journal-title":"PLoS Pathog"},{"issue":"26","key":"2019121906525052800_B66","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/bloodadvances.2017012534","article-title":"Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma","volume":"1","author":"Merryman","year":"2017","journal-title":"Blood Adv"},{"issue":"100","key":"2019121906525052800_B67","first-page":"237","article-title":"MicroRNAs regulate immune system via multiple targets","volume":"18","author":"Jia","year":"2014","journal-title":"Discov Med"},{"key":"2019121906525052800_B68","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1743-422X-10-314","article-title":"Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells","volume":"10","author":"Yang","year":"2013","journal-title":"Virol J"},{"issue":"5","key":"2019121906525052800_B69","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1158\/0008-5472.CAN-07-5126","article-title":"EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3","volume":"68","author":"Xia","year":"2008","journal-title":"Cancer Res"},{"issue":"16","key":"2019121906525052800_B70","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1007\/s00018-015-1922-2","article-title":"Principles of miRNA-mRNA interactions: beyond sequence complementarity","volume":"72","author":"Afonso-Grunz","year":"2015","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2019121906525052800_B71","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/cei.12954","article-title":"The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis","volume":"189","author":"Wang","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"2019121906525052800_B72","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/leu.2015.285","article-title":"EBV-miR-BHRF1-2 targets PRDM1\/Blimp1: potential role in EBV lymphomagenesis","volume":"30","author":"Ma","year":"2016","journal-title":"Leukemia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/25\/2261\/1549315\/bloodbld2019000889.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/25\/2261\/1549315\/bloodbld2019000889.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T06:53:36Z","timestamp":1576738416000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/134\/25\/2261\/422729\/EBV-microRNABHRF125p-targets-the-3UTR-of-immune"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":72,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2019,12,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019000889","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]}}}